A detailed history of Cetera Investment Advisers transactions in Mannkind Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 22,705 shares of MNKD stock, worth $168,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,705
Previous 21,232 6.94%
Holding current value
$168,925
Previous $96,000 22.92%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

BUY
$4.05 - $5.43 $5,965 - $7,998
1,473 Added 6.94%
22,705 $118,000
Q1 2024

May 24, 2024

BUY
$3.25 - $5.27 $69,004 - $111,892
21,232 New
21,232 $96,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.91B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.